Le Lézard
Classified in: Covid-19 virus
Subjects: LAW, AVO

Challenge to Curfew


MONTREAL, May 7, 2021 /CNW Telbec/ - The AQPSUD (Association québécoise pour la promotion de la santé des personnes utilisatrices de drogues) [Quebec association for drug user health promotion] filed a court challenge to the curfew today and will seek its suspension pending a decision on its merits. The application for the curfew suspension will be heard on Tuesday, May 11.

The AQPSUD would like to emphasize that it supports health and social measures that fight the spread of the virus while maintaining a social safety net. However, the curfew, which has not been scientifically proven to limit the spread of Covid-19, violates rights protected by the Canadian Charter by preventing drug users from accessing the health care they are entitled to.

Concurrently to the pandemic, there has been a devastating overdose crisis in the past years, with the number of overdoses increasing throughout the pandemic. The situation has become more critical since the introduction of the curfew in January. Overdoses tend to increase with the arrival of summer, and we are expecting a humanitarian disaster if the curfew is not lifted promptly.

Possessing drugs remains illegal and those who use them are more stigmatized than ever. Experience shows that we cannot rely on the police discretion-based public health exemption and attestation system to maintain access to health care between 9:30 p.m. and 5:00 a.m. for marginalized people. We believe without a doubt that the harm the curfew does to drug users far outweighs any benefits it may bring to the general population.

AQPSUD will be represented by Sibel Ataogul and Daniel Bélanger of Melançon Marceau Grenier Cohen, the same firm that successfully challenged the City of Montreal's P-6 by-law.

SOURCE Association Québécoise pour la promotion de la santé des personnes utilisatrices de drogues (AQPSUD)


These press releases may also interest you

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

18 avr 2024
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...



News published on and distributed by: